Three independent discounted-cash-flow-style models value Niagen Bioscience, Inc. Common Stock every trading day. 2 of 3 currently price NAGE above its market price.
| Free Cash Flow model | $3.46 |
| Excess Profit model | $2.79 |
| Residual Earnings model | $1.86 |
| Dividend Discount model | — |
| Piotroski F-Score | 3 / 4 |
| Return on invested capital | +14.9% |
| Net debt / EBITDA | -3.4× |
| Gross margin | +64.3% |
| Revenue CAGR | — |
| Cash conversion | 0.8× |
| Dividend yield | — |
| Buyback yield | — |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open NAGE in StockKitty